Compare Prospect Capital Corporation (PSEC) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Prospect Capital Corporation vs Revolution Medicines Inc. Common Stock — how do they compare? Prospect Capital Corporation trades at $1.78 (market cap $974.22M), while Revolution Medicines Inc. Common Stock trades at $190.87 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 41.4× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays a 23.01% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Prospect Capital Corporation for 78 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| PSEC | RVMD | |
|---|---|---|
Market Cap | $974.22M | $40.32B |
Volume | 5,779,996 | 4,855,734 |
Sector | Financials | Health |
52-Week High | $3.05 | $221.15 |
52-Week Low | $1.82 | $47.50 |
Typical Hold Time | 78 Days | 0 Days |
Enterprise Value | $2.73B | $37.02B |
Dividend Yield | 23.01% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PSEC trades at $1.80, down 2.17% today, with a bearish technical outlook showing 18 sell signals versus 5 buy signals. The company shows mixed fundamentals with a low P/B ratio of 0.33 but concerning profitability metrics including 1.01% ROE and negative revenue of -$407M for 2025. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $0.15 beating the $0.11 estimate. The stock pays a regular $0.04 monthly dividend, providing income appeal despite operational challenges.
PSEC presents a high-risk opportunity with significant challenges. The 62% NAV discount and consistent dividend payments offer value for income-focused investors, but persistent revenue volatility, negative cash flow, and bearish analyst sentiment (55% hold rating) suggest caution. Key risks include ongoing portfolio contraction and declining investment income, requiring careful monitoring of quarterly results and NAV stability for any turnaround signs.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →
